Patents by Inventor Ute Möllmann

Ute Möllmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibacterial sideromycins
    Patent number: 11149046
    Abstract: A compound, comprising: an Fe(III)-binding and/or Fe(III)-bound siderophore; one or more optional linker covalently bound to the siderophore; and daptomycin covalently bound to the linker, or, if no linker is present, then to the siderophore; or pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: October 19, 2021
    Assignee: HSIRI THERAPEUTICS, INC.
    Inventors: Marvin J. Miller, Yun-Ming Lin, Manuka Ghosh, Patricia A. Miller, Ute Möllmann
  • New Benzothiazinone Derivatives and Their Use as Antibacterial Agents
    Publication number: 20110160193
    Abstract: The present invention relates to novel benzothiazinone derivatives and their use as antibacterial agents in infectious diseases of mammals (humans and animals) caused by bacteria, especially diseases like tuberculosis (TB) and leprosy caused by mycobacteria. The present invention aims at the generation of new compounds with activity against mycobacteria as potential new tuberculosis drugs to overcome problems concerning resistance and drug intolerance. The solution of the present invention is a compound of formula I wherein R1 to R6 are as defined in the specification.
    Type: Application
    Filed: December 22, 2010
    Publication date: June 30, 2011
    Applicant: Leibniz Institute for Natural Product Research and Infection Biology E.V.
    Inventors: A. Vadim Makarov, Stewart T. Cole, Ute Möllmann
  • Benzothiazinone Derivatives and their Use as Antibacterial Agents
    Publication number: 20090239851
    Abstract: The present invention relates to novel benzothiazin derivatives and their use as antibacterial agents in infectious diseases of mammals (humans and animals) caused by bacteria, especially diseases like tuberculosis (TB) and leprosy caused by mycobacteria. The present invention aims at the generation of new compounds with activity against mycobacteria as potential new tuberculosis drugs to overcome problems concerning resistance and drug intolerance.
    Type: Application
    Filed: May 24, 2006
    Publication date: September 24, 2009
    Inventors: A. Vadim Makarov, Stewart T. Cole, Ute Möllmann
  • Method of treating infectious diseases with polysaccharide derivatives
    Patent number: 7297687
    Abstract: The present invention relates to a method of treating infectious diseases, that involves: (a) providing an alpha-glycosidically linked starch polysaccharide derivative; and (b) inhibiting the growth of an infectious disease by administering a composition comprising the alpha-glycosidically linked starch polysaccharide derivative. The alpha-glycosidically linked starch polysaccharide derivative represented by the following general formula I, in which: the alpha-glycosidically linked starch polysaccharide derivative has a degree of quaternary ammonium group substitution of from 0.4 to 2.
    Type: Grant
    Filed: January 10, 2003
    Date of Patent: November 20, 2007
    Assignee: Wolff Cellulosics GmbH Co. KG
    Inventors: Vera Haack, Thomas Heinze, Michaela Schmidtke, Ute Möllmann, Hans-Martin Dahse, Albert Härtl